clinical trial · NCT07465289
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
UCB Biopharma SRL·phase3·not yet recruiting·n = 100
Ocular Myasthenia GravisRozanolixizumab
brief summary
The purpose of the study is to assess the long-term safety and efficacy of rozanolixizumab in adult study participants with ocular myasthenia gravis.
started
Jul 27, 2026
primary completion
Jan 23, 2031
completion
Jan 23, 2031
last updated
Mar 11, 2026
official title
A Phase 3, Open-Label, Extension Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol